Pain And Therapy

Journal Title：Pain And Therapy

Pain and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of pain therapies and pain-related devices. Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, acute pain, cancer pain, chronic pain, headache and migraine, neuropathic pain, opioids, palliative care and pain ethics, peri- and post-operative pain as well as rheumatic pain and fibromyalgia.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports, trial protocols, short communications such as commentaries and editorials, and letters. The journal is read by a global audience and receives submissions from around the world. Pain and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

《疼痛与治疗》是一本国际性、开放获取、同行评审、快速出版的期刊，致力于发表高质量的临床（所有阶段）、观察性、真实世界和健康结果研究，研究内容涉及疼痛疗法和疼痛相关设备的发现、开发和使用。还鼓励发表与诊断、药物经济学、公共卫生、生活质量以及患者护理、管理和教育相关的研究。

重点领域包括但不限于急性疼痛、癌痛、慢性疼痛、头痛和偏头痛、神经性疼痛、阿片类药物、姑息治疗和疼痛伦理、围手术期和术后疼痛以及风湿性疼痛和纤维肌痛。

该期刊受到广大制药和医疗保健专业人士的关注，发表原创研究、综述、病例报告、试验方案、简短通讯（如评论和社论）和信件。该期刊的读者遍布全球，并收到来自世界各地的投稿。 《疼痛与治疗》将考虑所有科学合理的研究，无论是正面数据、确认数据还是负面数据。无论投稿涉及国际和/或特定国家/地区的受众，我们都欢迎投稿，当研究人员试图针对更具体的患者群体时，这一点至关重要。这种包容性方法使该期刊能够协助传播所有科学和伦理合理的研究。

Pain And Therapy创刊于2012年，由Springer Healthcare出版商出版，收稿方向涵盖CLINICAL NEUROLOGY全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 6 Weeks ，影响因子指数4.1，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。